Anthropic and Danish Company behind Ozempic announce AI drug discovery collaboration

Danish pharmaceutical company Novo Nordisk is partnering with American artificial intelligence company Anthropic, aiming to use Anthropic’s Claude model to advance its drug discovery research and development. Novo, the developer of the popular weight loss drug Ozempic, announced the partnership on Wednesday, saying it will help the company in its mission to become “the world’s […]

Read it at Washington Examiner ↗

← Front page